Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element

被引:15
作者
Flick, MB
Sapi, E
Kacinski, BM
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
关键词
macrophage colony-stimulating factor receptor; dexamethasone; AP-1; proteins;
D O I
10.1002/jcb.10102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported that glucocorticoids markedly increase and anti-glucocorticoids (such as RU-486) block c-fms RNA and protein expression in some breast cancer cell lines, but not in others, and that this increase is the consequence of increased transcription from the first, epithelial cell-specific promoter of the c-fms gene (encoding CSF-1R, macrophage colony-stimulating factor receptor). Employing DNasel protection and electrophoretic mobility shift assays (EMSA), we now demonstrate that DNA-transcription factor protein complexes are formed on the c-firs first promoter at a composite regulatory element containing overlapping binding sites for AP-1 proteins, bHLH factors, and the glucocorticoid receptor (GR). Competition studies indicate that transcription factor proteins bind the AP-1 site and the GR element (GRE) and both GR and AP-1 proteins are involved in DNA-protein complex formation. The complexes differ in quantity and glucocorticoid inducibility in the different breast cancer cell lines studied depending on whether the promoter responds to glucocorticoid stimulation. Transient transfection of promoter/reporter gene constructs resulted in reduced basal transcription activity of this promoter and lack of glucocorticoid stimulation when the AP-1 site was mutated. We conclude that AP-1 proteins, GR and associated co-factors regulate transcription from the c-fms first promoter and that differences in recruitment of the various components are responsible for cell specific repression and activation of this gene in breast carcinoma cell lines. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:10 / 23
页数:14
相关论文
共 47 条
[1]  
Bamberger AM, 1999, INT J CANCER, V84, P533, DOI 10.1002/(SICI)1097-0215(19991022)84:5<533::AID-IJC16>3.0.CO
[2]  
2-J
[3]   Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter [J].
Chavez, S ;
Beato, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :2885-2890
[4]  
Chen TK, 1996, MOL CARCINOGEN, V15, P215, DOI 10.1002/(SICI)1098-2744(199603)15:3<215::AID-MC7>3.0.CO
[5]  
2-G
[6]  
COBIANCHI F, 1987, METHOD ENZYMOL, V152, P94
[7]   TRANSCRIPTION FACTOR INTERACTIONS - SELECTORS OF POSITIVE OR NEGATIVE REGULATION FROM A SINGLE DNA ELEMENT [J].
DIAMOND, MI ;
MINER, JN ;
YOSHINAGA, SK ;
YAMAMOTO, KR .
SCIENCE, 1990, 249 (4974) :1266-1272
[8]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895
[9]  
FILDERMAN A, 1992, CANCER RES, V552, P3661
[10]   IMMUNOCYTOCHEMICAL LOCALIZATION OF FOS PROTEIN IN HUMAN BREAST CANCERS AND ITS RELATIONSHIP TO A SERIES OF PROGNOSTIC MARKERS AND RESPONSE TO ENDOCRINE THERAPY [J].
GEE, JMW ;
ELLIS, IO ;
ROBERTSON, JFR ;
WILLSHER, P ;
MCCLELLAND, RA ;
HEWITT, KN ;
BLAMEY, RW ;
NICHOLSON, RI .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :269-273